Acta Scientific Ophthalmology (ISSN: 2582-3191)

Research Article Volume 5 Issue 8

Trends in Practice Patterns of General Ophthalmologists, Glaucoma and Retina Specialists on the Management of Neovascular Glaucoma in the Philippines

Jesse James M Lu*, Rainier Victor A Covar and Darby E Santiago

Department of Ophthalmology and Visual Sciences, Sentro Oftalmologico Jose Rizal, University of the Philippines - Philippine General Hospital, Taft Avenue, Metro Manila, Philippines

*Corresponding Author: Jesse James M Lu, Department of Ophthalmology and Visual Sciences, Sentro Oftalmologico Jose Rizal, University of the Philippines - Philippine General Hospital, Taft Avenue, Metro Manila, Philippines.

Received: July 13, 2022; Published: July 19, 2022

Abstract

Purpose: Neovascular glaucoma (NVG) is a dreaded form of secondary glaucoma characterized by neovascularization of the iris, the angle, or both, and elevation of intraocular pressure (IOP). Because of the complex nature of the disease, its treatment often warrants a multi-disciplinary approach that inevitably lead to variations in treatment protocols. In this research, we are interested in determining the different treatment practices in the management of NVG among general ophthalmologists, glaucoma specialists and retina specialists based on the presenting stage of the disease.

Objective: This study aimed to compare the different treatment practices among general ophthalmologists, glaucoma and retina subspecialists in the management of neovascular glaucoma.

Methodology: A cross-sectional survey study among general ophthalmologists, glaucoma and retina specialists who are members of the Philippine Academy of Ophthalmology (PAO) was conducted. The survey, drafted by a general ophthalmologist, a glaucoma specialists and a retina specialist, comprised of seventeen questions in multiple choice format with two parts. The first part included questions pertaining to participant demographics, while the second part consisted of questions pertaining to their NVG management practices.

Results: One hundred and sixty four (164) respondents were included in the survey comprising of 67 general ophthalmologists, 47 glaucoma specialists and 50 retina specialists. Most of the participants practice in an area with an available retina and glaucoma specialist, and have access to anti-vascular endothelial growth factor (anti-VEGF) medication or pan-retinal photocoagulation (PRP). The participants have varied years of practice or experience. On the average, general ophthalmologists and retina specialists (VRSP) are able to see less than 1 case of NVG per month; whereas glaucoma specialists (PGS and non-PGS) and retina specialists (non-VRSP) are able to see more than 1 case of NVG per month. The most common first line medication used by almost all subspecialty with an IOP between 30 and 40 mmHg is a beta blocker. On the other hand, the most common first line medication used by all subspecialty for IOP of more than 40 mmHg is an oral carbonic anhydrase inhibitor (CAI). The usual and preferred anti-VEGF drug used by all subspecialties is bevacizumab. All ophthalmologists perform and prefer to do IOP surgery within 7 days after anti-VEGF injection. During the early stage of the disease, majority of the respondents will either inject anti-VEGF or perform PRP. Forty percent of glaucoma specialists will refer the patient to a retina specialist. During the open angle stage, only 60% of general ophthalmologists will manage the disease on their own either with anti-VEGF inejction of PRP. Forty percent of them will either refer to a glaucoma or a retina specialist. During the angle closure stage, majority of the respodents would inject anti-VEGF as their initial management. One-third of general ophthalmologists will refer to either a glaucoma or a retina specialist. Twenty one percent of glaucoma specialists will immediately refer the patient to a retina specialist, while 12% of retina specialists will refer to a glaucoma specialist. Trabeculectomy was the IOP lowering surgery of choice of general ophthalmologists during this stage, whereas the glaucoma specialists preferred glaucoma drainage device (GDD) implantation.

Conclusions: The survey identified similarities and differences in practice patterns between specialist and non-specialists in our local setting. It highlighted the complexity of NVG management and the different treatment approach by different specialties. Although there was an agreement between both general and subspecialty practice for the use of anti-VEGF medication as first line treatment as shown in the study, differences exist within the practice regarding the next step in the management. Thus, a need for a consensus or society guidelines regarding NVG management may be necessary to reduce these discrepancies for the sake of a more prompt and efficient therapy.

Keywords: Neovascular Glaucoma; anti-VEGF; Pan-retinal Photocoagulation; Trabeculectomy; Glaucoma Drainage Device; Philippines

References

  1. Rodrigues G., et al. “Neovascular glaucoma: a review”. International Journal of Retina and Vitreous 2 (2016): 26-35.
  2. Yang H., et al. “Neovascular glaucoma: Handling in the future”. Taiwan Journal of Ophthalmology2 (2018): 60-66.
  3. Allingham R., et al. “Shields’ Textbook of Glaucoma, e 5”. Lippincott Williams and Wilkins, Philadelphia, 2005. Glaucomas Associated with Disorders of the Retina, Vitreous, and Choroid (2005): 328-341.
  4. Havens S and Gulati V. “Neovascular Glaucoma”. Developments in Ophthalmology 55 (2016): 196-204.
  5. Florcruz N., et al. “Profile of Glaucoma Cases Seen at a Tertiary Referral Hospital”. Philippine Journal of Ophthalmology 4 (2005): 161-165.
  6. Martinez J and Hosaka M. “Clinical Profile and Demographics of Glaucoma Patients Managed in a Philippine Tertiary Hospital”. Philippine Journal of Ophthalmology 40 (2015): 81-87.
  7. Leuenderger A., et al. “Comparison of the Clinical Profile of Patients with Glaucoma Between Private and Government Clinics in the Philippines”. Philippine Journal of Ophthalmology 2 (2019): 45-53.
  8. Olmos L C and Lee RK. “Medical and Surgical Treatment of Neovascular Glaucoma”. International Ophthalmology Clinics 51.3 (2011): 27-36.
  9. Aref A. “Management of immediate and sustained intraocular pressure rise associated with intravitreal anti vascular endothelial growth factor injection therapy”. Current Opinion in Ophthalmology 23 (2012): 105-110.
  10. Aref A. “Current management of glaucoma and vascular occlusive disease”. Current Opinion in Ophthalmology 27 (2016): 140-145.
  11. Olmos LC., et al. “Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab”. Eye 30 (2015): 460-472.
  12. Tang M., et al. “Efficacy of intravitreal ranibizumab combined with Ahmed glaucoma valve implantation for the treatment of neovascular glaucoma”. BMC Ophthalmology 16 (2016):

Citation

Citation: Jesse James M Lu., et al. “Trends in Practice Patterns of General Ophthalmologists, Glaucoma and Retina Specialists on the Management of Neovascular Glaucoma in the Philippines".Acta Scientific Ophthalmology 5.8 (2022): 58-68.

Copyright

Copyright: © 2022 Jesse James M Lu., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US